Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: resumen ejecutivo de GOLD / Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD executive summary
Arch. bronconeumol. (Ed. impr.)
; 53(3): 128-149, mar. 2017. tab, ilus
Article
in Spanish
| IBECS
| ID: ibc-161798
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Este resumen ejecutivo del Informe de 2017 de la Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) se basa principalmente en las modificaciones y novedades del documento anterior. Los cambios más destacados incluyen a) se ha diferenciado entre la exploración espirométrica y la de los síntomas para evaluar la enfermedad pulmonar obstructiva crónica (EPOC). En la propuesta actual, los grupos ABCD se refieren exclusivamente a síntomas y antecedentes de exacerbaciones de los pacientes; b) para cada uno de los grupos, se proponen estrategias de intensificación de los tratamientos farmacológicos; c) se introduce el concepto de reducción escalonada de la terapia en el esquema de evaluación del tratamiento; d) se detalla más extensamente el tratamiento no farmacológico; y, f) se revisa la importancia de las diferentes co-morbilidades en lo que respecta al tratamiento de la EPOC
ABSTRACT
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed
Full text:
Available
Collection:
National databases
/
Spain
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Goal 10: Communicable diseases
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
IBECS
Main subject:
Risk Factors
/
Disease Progression
/
Pulmonary Disease, Chronic Obstructive
/
Annual Reports as Topic
Type of study:
Diagnostic study
/
Etiology study
/
Risk factors
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Arch. bronconeumol. (Ed. impr.)
Year:
2017
Document type:
Article
Institution/Affiliation country:
Brigham and Women's Hospital Boston/EE.UU
/
Flinders University/Australia
/
Hospital Clínic/España
/
Hôpital Cochin (APHP)/Francia
/
Imperial College London/Reino Unido
/
Instituto de Enfermedades Respiratorias de Guangzhou/China
/
McGill University/Canadá
/
National Heart and Lung Institute/Reino Unido
/
New York-Presbyterian Hospital/EE.UU
/
Royal Devon & Exeter Hospital/Reino Unido